MAPT and Alzheimer disease: We examined the association of age-residualized cerebrovascular biomarker levels, which reflect the extent to which the biomarker severity deviates from the value predicted by age, with demographic variables, vascular risk factors, amyloid and tau burden, and AD diagnosis (Table 2).